<DOC>
	<DOCNO>NCT00000858</DOCNO>
	<brief_summary>To correlate HIV-1 viral load vaginocervical secretion ( VCS ) , measured culture nucleic acid detection , find peripheral blood HIV clinical status . To determine whether systemic local HIV specific antibody influence quality type virus isolate VCS . To ascertain whether presence specific infectious agent ( e.g. , HPV , HSV , CMV , etc . ) influence amount type virus isolate VCS . Predictors development acquire immunodeficiency syndrome ( AIDS ) HIV infected individual study primarily among adult male select small population . Although many predictor may relevant woman , HIV infection manifest differently sex . Therefore , important study spectrum HIV disease woman identify unique common marker , cofactor , predictor disease progression .</brief_summary>
	<brief_title>Detection Human Immunodeficiency Virus Type 1 ( HIV-1 ) Vaginocervical Secretions : Correlation With Clinical Status , Virologic Immunologic Parameters , Presence Other Infections</brief_title>
	<detailed_description>Predictors development acquire immunodeficiency syndrome ( AIDS ) HIV infected individual study primarily among adult male select small population . Although many predictor may relevant woman , HIV infection manifest differently sex . Therefore , important study spectrum HIV disease woman identify unique common marker , cofactor , predictor disease progression . Part 009 : HIV-infected female adult , independent CD4+ cell count , provide blood VCS specimen obtain single study visit , regardless ovulatory phase . NOTE : Subjects study patient currently enrol multisite longitudinal study , Women 's Interagency HIV Study ( WIHS ) , design elucidate natural history infection HIV-1 U.S. woman . Participation DATRI 009 require additional blood patient 's schedule WIHS visit . Part 009a : Consent obtain 65 woman allow additional evaluation complete reserve VCS specimen additional peripheral blood specimen , specifically obtain DATRI 009a 009 visit . An additional 8 ml CPT tube collect patient , bring total blood volume 32 ml schedule WIHS visit .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Inclusion Criteria Patients must : Premenopausal status . Intact uterus cervix . Documented HIV infection . Current enrollment multisite longitudinal study , Women 's Interagency HIV Study ( WIHS ) . Required : Stable antiretroviral therapy within 1 month prior study entry . Exclusion Criteria Concurrent Medication : Excluded : Antifungal antimicrobial medication vagina . Prior Medication : Excluded : Antimicrobial antifungal medication 48 hour prior study entry . Use spermicide douche 48 hour prior entry . Coital interaction 48 hour prior study visit , report subject confirm negative seminal fluid assay result .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 1998</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Vagina</keyword>
</DOC>